Levine Deborah A
Department of Pediatrics, New York University School of Medicine, Bellevue Hospital Center, New York 10016, USA.
Curr Opin Pediatr. 2008 Jun;20(3):261-5. doi: 10.1097/MOP.0b013e328300ecdc.
Novel therapies, such as a heliox gaseous mixture and noninvasive bilevel positive pressure ventilation, are being utilized in the treatment of the patient with severe asthma who is unresponsive to conventional medical management. Aggressive treatment may prevent intubation and its untoward complications.
Both heliox and bilevel positive pressure ventilation have demonstrated clinical improvement in studies of patients refractory to standard care, both in adults and children.
The studies in children are limited but show promise, especially when these therapies are used early in the treatment course and in certain subsets of patients.
新型疗法,如氦氧混合气体和无创双水平正压通气,正被用于治疗对传统药物治疗无反应的重度哮喘患者。积极治疗可预防插管及其不良并发症。
氦氧混合气和双水平正压通气在针对标准治疗无效患者(包括成人和儿童)的研究中均显示出临床改善效果。
儿童相关研究有限,但前景良好,尤其是在治疗过程早期及某些特定患者亚组中使用这些疗法时。